ImmunologyFrontiers in Cellular NeurosciencePeer-reviewed
TPPB modulates PKC activity to attenuate neuroinflammation and ameliorate experimental multiple sclerosis
Shruthi Shanmukha, Wesley H. Godfrey, Payam Mohammad Gharibani…·Paul M. Kim
This study shows TPPB, a new PKC modulator, reduces neuroinflammation and promotes CNS repair in experimental MS by targeting innate immune cells.
5 citations